10. Vaccine-Induced HIV-Seropositivity10. Vaccine-Induced HIV-Seropositivity

Vaccine-Induced HIV-Seropositivity. Consensus: The sponsor must provide the capacity for differential confirmatory testing for ... UNAIDS-Sponsored Regional Workshops to Discuss Ethical Issues in Preventive HIV Vaccine Trials (UNAIDS, 2000, 52 p.). ...
more infohttp://www.nzdl.org/gsdlmod?e=d-00000-00---off-0unaids--00-0----0-10-0---0---0direct-10---4-------0-1l--11-en-50---20-about---00-0-1-00-0--4----0-0-11-10-0utfZz-8-00&cl=CL1.6&d=HASH2f8be7da9bb2eef632f98a.4.2.10>=1

NIOSHTIC-2  Publications Search - 00186999 - HIV seropositivity in i.v. drug users in Ohio.NIOSHTIC-2 Publications Search - 00186999 - HIV seropositivity in i.v. drug users in Ohio.

HIV) infection among intravenous (iv) drug users in Ohio. The Ohio Department of Health (ODH) undertook a study of methadone ... educational efforts to prevent HIV transmission in the drug using population of Ohio with apparently low HIV seroprevalence ... Of the seven HIV cases, three gave histories of having shared a needle in New York City since 1981. Being Black or Hispanic and ... Of these, seven (1.4 percent) were seropositive for HIV. The sexual orientation of the whole group was primarily heterosexual, ...
more infohttps://www.cdc.gov/niosh/nioshtic-2/00186999.html

P14.16 Self reported hiv discrimination and willingness to disclose hiv seropositivity among a sample of turks and caicos...P14.16 Self reported hiv discrimination and willingness to disclose hiv seropositivity among a sample of turks and caicos...

P14.16 Self reported hiv discrimination and willingness to disclose hiv seropositivity among a sample of turks and caicos ... P14.16 Self reported hiv discrimination and willingness to disclose hiv seropositivity among a sample of turks and caicos ... including the likelihood of HIV seropositivity disclosure. Knowledge about ones partners seropositivity can guide both the ... Results Nearly half of the participants were unwilling to disclose HIV seropositivity (44.8%). Moreover, willingness to ...
more infohttp://sti.bmj.com/content/91/Suppl_2/A204.1

When Is Public Decision Disclosure of HIV Seropositivity Acceptable?When Is Public Decision Disclosure of HIV Seropositivity Acceptable?

Aids; Disclosure; Discrimination; Health; Health Care; HIV Seropositivity; Public Health; Risks and Benefits; Stigmatization; ... When Is Public Decision Disclosure of HIV Seropositivity Acceptable?. Creator. Muula, Adamson S. ... While public disclosure of HIV status has a place in the fight against HIV and AIDS, especially by resulting in behavioural ... HIV/AIDS is a major public health problem in Africa. Stigmatization, discrimination and lack of appropriate health care are ...
more infohttps://repository.library.georgetown.edu/handle/10822/981858

Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa - Full Text View -...Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa - Full Text View -...

HIV seropositivity. *Intention to exclusively breastfeed for 6 months. *Ability to give informed consent ... HIV Protease Inhibitors. Protease Inhibitors. Enzyme Inhibitors. Molecular Mechanisms of Pharmacological Action. Anti-HIV ... Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa. The safety and ... HIV Negative Survival of Infants [ Time Frame: to be assessed at: infant age 6 months, 3 months post-weaning from breastfeeding ...
more infohttps://clinicaltrials.gov/show/NCT01088516?order=258

Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+ - Full Text View - ClinicalTrials.govEffectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+ - Full Text View - ClinicalTrials.gov

HIV Seropositivity. HIV Infections. Lentivirus Infections. Retroviridae Infections. RNA Virus Infections. Virus Diseases. ... HIV Seropositivity Other: ARVs + Placebo Drug: Naltrexone Drug: Naltrexone + ARVs Phase 2 ... In the vast majority of those infected with HIV virus who are untreated, there is deterioration in immune health over a period ... Due to toxicity of current ARV drugs and need for special medical management young HIV infected children are largely neglected ...
more infohttps://clinicaltrials.gov/show/NCT01174914?order=131

Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and...Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and...

HIV-seropositivity; and maternal age ≤ 25 years (risk for peripheral and placental blood parasitemia only). Maternal anemia ( ... and HIV infection) are important risk factors for malaria in pregnant women, the use of an ineffective intervention (CQ in a ... HIV) (persistent infections only); and no use of antimalarial prophylaxis before enrollment (breakthrough infections only). At ... HIV-seropositivity; and maternal age ≤ 25 years (risk for peripheral and placental blood parasitemia only). Maternal anemia ( ...
more infohttp://www.ajtmh.org/content/journals/10.4269/ajtmh.1996.55.24

A Comparative Study of Mefloquine and S-P as Prophylaxis Against Malaria in Pregnant HIV + Patients | AIDSinfoA Comparative Study of Mefloquine and S-P as Prophylaxis Against Malaria in Pregnant HIV + Patients | AIDSinfo

ClinicalTrials.gov summary of A Comparative Study of Mefloquine and S-P as Prophylaxis Against Malaria in Pregnant HIV + ... HIV positive Prevention Additional relevant MeSH terms: Malaria HIV Seropositivity Pyrimethamine Sulfadoxine Fanasil, ... Malaria in Pregnant HIV + Patients Drug : Mefloquine. Drug : Sulphadoxine-Pyrimethamine. Phase 1. ... A Comparative Study of Mefloquine and S-P as Prophylaxis Against Malaria in Pregnant HIV + Patients The recruitment status of ...
more infohttps://aidsinfo.nih.gov/clinical-trials/details/NCT02524444

The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in...The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in...

History of HIV seropositivity. * Disseminated MAC. * Positive blood culture for MAC within 4 weeks prior to study entry. * ... HIV Infections Mycobacterium Infections Mycobacterium avium-intracellulare Infection Clarithromycin Ethambutol Clofazimine ... Active therapy with investigational drugs other than treatment for HIV disease, except with approval of the sponsor. * ...
more infohttps://aidsinfo.nih.gov/clinical-trials/details/NCT00002331

Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care.Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care.

Data were obtained through the linkage of two separate studies: the UK Collaborative HIV Cohort study (UK CHIC), a coho ... To describe predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care. ... HIV Seropositivity / epidemiology*. Humans. Incidence. Infectious Disease Transmission, Vertical / prevention & control, ... CONCLUSION: The pregnancy rate among women accessing HIV clinical care increased in 2000-2009. HIV-positive women with, or ...
more infohttp://www.biomedsearch.com/nih/Predictors-pregnancy-changes-in-incidence/22713479.html

TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPDTLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD

HIV seropositivity.. - Severe psychological illness.. EXCLUSION CRITERIA - RELATED DONORS. - Identical twin. - Any contra- ...
more infohttp://www.knowcancer.com/cancer-trials/NCT00185796/

Dr. Martha F Rogers MD Locations | Tonganoxie, KS | Vitals.comDr. Martha F Rogers MD Locations | Tonganoxie, KS | Vitals.com

HIV Seropositivity * AIDS-Related Opportunistic Infections * Pregnancy Complications, Infectious * Diabetes, Type 2 ...
more infohttps://www.vitals.com/doctors/Dr_Martha_Rogers.html

Credentials | Dr. Elaine Abrams, MD | New York, NY | Pediatrician | VitalsCredentials | Dr. Elaine Abrams, MD | New York, NY | Pediatrician | Vitals

HIV Seropositivity * Immunization * Pediatric Diabetes * Physical * Pregnancy Complications, Infectious * Prenatal Exposure ...
more infohttps://www.vitals.com/doctors/Dr_Elaine_Abrams/credentials

NLM Gateway ResultsNLM Gateway Results

A rapid assessment of Vietnamese sex workers working in Cambodia: high risk of HIV transmission upon entry into Cambodia. ... of brothel-based sex workers in Cambodia are HIV infected. Thus, VN-SWs may be at high risk for HIV infection. In 2002, we ... Although HIV prevalence among Vietnamese sex workers (VN-SWs) in Cambodia is not known, it is estimated that 29% ... Ninety-five percent reported seeking STI services and HIV/AIDS education in Cambodia, but only 10% understood the local ...
more infohttps://gateway.nlm.nih.gov/result_am?query=A%20rapid%20assessment%20of%20Vietnamese%20sex%20workers%20working%20in%20Cambodia&id=102283060&itemnum=1&amhighlight=Yes&amsort=Relevance

Optimized Antiretroviral Therapy(ART)During Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in HIV-1 IndividualsOptimized Antiretroviral Therapy(ART)During Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in HIV-1 Individuals

To find out if it is possible for HIV-1 patients to maintain antiretroviral medications during allogeneic bone marrow ... 1. HIV-1 infection, as documented by a rapid HIV-1 test or any FDA-approved HIV-1 enzyme. or chemiluminescence immunoassay (E/ ... HIV Seropositivity. .map{width:100%;height:300px;margin-bottom:15px}. Name. Location. ... Alternatively, two HIV-1 RNA values > 200 copies/mL. at least 24 hours apart performed by any laboratory that has CLIA ...
more infohttp://www.knowcancer.com/cancer-trials/NCT01836068/

Robert S Hoggs Research on Highly Active Antiretroviral Therapy (HAART)
     | CureHunterRobert S Hogg's Research on Highly Active Antiretroviral Therapy (HAART) | CureHunter

HIV Infections (HIV Infection) 08/2010 - 09/2003. 3. HIV Seropositivity 01/2009 - 01/2003. ... Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the " ... HAART slows progression to anal cancer in HIV-infected MSM.. 1/2014. The effect of history of injection drug use and alcoholism ... The Holy Grail: The search for undiagnosed cases is paramount in improving the cascade of care among people living with HIV.. ...
more infohttp://www.curehunter.com/public/authorSummary-Hogg,%20Robert%20S.do?keywordId=D023241

UNAIDS-Sponsored Regional Workshops to Discuss Ethical Issues in Preventive HIV Vaccine Trials  (UNAIDS, 2000, 52 p.): WORKSHOP...UNAIDS-Sponsored Regional Workshops to Discuss Ethical Issues in Preventive HIV Vaccine Trials (UNAIDS, 2000, 52 p.): WORKSHOP...

Vaccine-Induced HIV-Seropositivity. 11. Counselling. 12. Post-Exposure Prophylaxis (PEP). 13. Treatment and Care. ... UNAIDS-Sponsored Regional Workshops to Discuss Ethical Issues in Preventive HIV Vaccine Trials (UNAIDS, 2000, 52 p.). ...
more infohttp://www.nzdl.org/gsdlmod?e=d-00000-00---off-0unaids--00-0----0-10-0---0---0direct-10---4-------0-1l--11-en-50---20-about---00-0-1-00-0--4----0-0-11-10-0utfZz-8-00&a=d&c=unaids&cl=CL1.6&d=HASH2f8be7da9bb2eef632f98a.4.2.6

Susan Kegeles, PhD | The Center for Health and CommunitySusan Kegeles, PhD | The Center for Health and Community

Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda.. Annals of behavioral medicine : a ... Should HIV prevention strategies for young gay men be different for HIV-negative, HIV-positive, and untested men?. AIDS ... Learning to Live With HIV in the Rural Townships: A Photovoice Study of Men Who Have Sex With Men Living With HIV in Mpumalanga ... Sexually transmitted disease and HIV prevalence and risk factors in concentrated and generalized HIV epidemic settings. AIDS ...
more infohttps://chc.ucsf.edu/people/susan-kegeles-phd

Mohammad Hameed[Author] - PubMed - NCBIMohammad Hameed[Author] - PubMed - NCBI

Time series cross-correlation analysis of HIV seropositivity and pulmonary tuberculosis among migrants entering Kuwait. ...
more infohttps://www.ncbi.nlm.nih.gov/pubmed?term=Mohammad++Hameed%5BAuthor%5D

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patientsLiver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients

HIV seropositivity accelerates HCV-related liver fibrosis progression. In coinfected patients, a low CD4 count, alcohol ... A cohort of 122 HIV-HCV coinfected patients was compared with a control group of 122 HIV-negative HCV-infected patients. Groups ... HIV seropositivity (P < .0001), alcohol consumption (>50 g/d, P = .0002), age at HCV infection (. < .0001), and severe ... The aim of this work was to assess the fibrosis progression rate in HIV-HCV coinfected patients and in patients infected by HCV ...
more infohttp://natap.org/2013/HCV/022613_04.htm

High prevalence of HIV infection among youth in a South African mining town 
is associated with HSV-2 seropositivity and sexual...High prevalence of HIV infection among youth in a South African mining town is associated with HSV-2 seropositivity and sexual...

The findings of this study confirm the importance of adherence on HIV outcome as described recently in a different cohort [12 ... referred from HIV clinics in Philadelphia.. Main outcome measures: The primary outcome was undetectable viral load (< 50 copies ... This ia an interesting article about adherence and how much adherence is required to achieve longterm fully suppressed HIV. ... it was the most commonly prescribed highly active agent in protease inhibitor naive subjects at the Philadelphia HIV clinic ...
more infohttp://www.natap.org/2001/dec/122701_2.htm

Genitourinary Clinical Trials | Rutgers Cancer Institute of New JerseyGenitourinary Clinical Trials | Rutgers Cancer Institute of New Jersey

No known history of HIV seropositivity. * No known uncontrolled, underlying pulmonary disease (spirometry and DLCO ≤ 50% of ...
more infohttp://cinj.org/network-hospitals/genitourinary-clinical-trials